Physician profile
Timothy E Carter
NPI 1861456873
$1,223.81
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $567 · 2021: $418.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.92 | 2020-2021 | |
| Pfizer INC. | $213.24 | 2019-2020 | |
| Astellas Pharma US INC | $125.46 | 2019-2021 | |
| Avion Pharmaceuticals | $90.54 | 2019-2021 | |
| Allergan, INC. | $80.40 | 2019-2020 | |
| Novo Nordisk INC | $67.23 | 2019-2021 | |
| Therapeuticsmd, INC. | $65.83 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.89 | 2020-2021 | |
| Coopersurgical, INC. | $44.71 | 2019-2021 | |
| Radius Health, INC. | $32.79 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $29.51 | 2020-2021 | |
| Eisai INC. | $19.26 | 2020 | |
| Aspira Women'S Health INC | $17.27 | 2021 | |
| Hologic Sales and Service, LLC | $17.14 | 2019 | |
| Duchesnay USA Incorporated | $15.78 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.46 | 2020 | |
| Exeltis, USA INC. | $14.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.16 | 2021 | |
| Dysis Medical, INC. | $13.13 | 2020 | |
| Avanos Medical | $12.47 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.30 | 2020 | |
| Evofem Biosciences, INC. | $11.64 | 2021 | |
| Medline Industries LP | $11.20 | 2019 | |
| Minerva Surgical, INC | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.